108 related articles for article (PubMed ID: 34375652)
1. Higher oral efficacy of ravuconazole in self-nanoemulsifying systems in shorter treatment in experimental chagas disease.
Spósito PÁ; Mazzeti AL; de Castro KCMP; Mendes PF; Urbina JA; Bahia MT; Mosqueira VCF
Exp Parasitol; 2021 Sep; 228():108142. PubMed ID: 34375652
[TBL] [Abstract][Full Text] [Related]
2. Ravuconazole self-emulsifying delivery system: in vitro activity against
Spósito PÁ; Mazzeti AL; de Oliveira Faria C; Urbina JA; Pound-Lana G; Bahia MT; Mosqueira VF
Int J Nanomedicine; 2017; 12():3785-3799. PubMed ID: 28553114
[TBL] [Abstract][Full Text] [Related]
3. Listen to what the animals say: a systematic review and meta-analysis of sterol 14-demethylase inhibitor efficacy for in vivo models of Trypanosoma cruzi infection.
Bisio MMC; Jurado Medina LS; García-Bournissen F; Gulin JEN
Parasitol Res; 2024 Jun; 123(6):248. PubMed ID: 38904688
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease.
Urbina JA; Payares G; Sanoja C; Lira R; Romanha AJ
Int J Antimicrob Agents; 2003 Jan; 21(1):27-38. PubMed ID: 12507835
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
[TBL] [Abstract][Full Text] [Related]
6. Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.
Diniz Lde F; Caldas IS; Guedes PM; Crepalde G; de Lana M; Carneiro CM; Talvani A; Urbina JA; Bahia MT
Antimicrob Agents Chemother; 2010 Jul; 54(7):2979-86. PubMed ID: 20404124
[TBL] [Abstract][Full Text] [Related]
7. Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice.
Diniz LF; Mazzeti AL; Caldas IS; Ribeiro I; Bahia MT
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555633
[TBL] [Abstract][Full Text] [Related]
8. Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study.
Mazzeti AL; Diniz LF; Gonçalves KR; Nascimento AFS; Spósito PAF; Mosqueira VCF; Machado-Coelho GLL; Ribeiro I; Bahia MT
Biochem Pharmacol; 2018 Feb; 148():213-221. PubMed ID: 29309767
[TBL] [Abstract][Full Text] [Related]
9. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F
Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982
[TBL] [Abstract][Full Text] [Related]
10. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DDGJ; Da Silva CF; Pavão BP; Batista MM; Moreira OC; Souza LRQ; Britto C; Rachakonda G; Villalta F; Lepesheva GI; Soeiro MNC
ACS Infect Dis; 2019 Mar; 5(3):365-371. PubMed ID: 30625275
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
[TBL] [Abstract][Full Text] [Related]
12. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi.
Molina J; Brener Z; Romanha AJ; Urbina JA
J Antimicrob Chemother; 2000 Jul; 46(1):137-40. PubMed ID: 10882704
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
[TBL] [Abstract][Full Text] [Related]
14. Amlodipine Increases the Therapeutic Potential of Ravuconazole upon Trypanosoma cruzi Infection.
Machado YA; Bahia MT; Caldas IS; Mazzeti AL; Novaes RD; Vilas Boas BR; Santos LJS; Martins-Filho OA; Marques MJ; Diniz LF
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423960
[TBL] [Abstract][Full Text] [Related]
15. Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity.
Franco CH; Warhurst DC; Bhattacharyya T; Au HYA; Le H; Giardini MA; Pascoalino BS; Torrecilhas AC; Romera LMD; Madeira RP; Schenkman S; Freitas-Junior LH; Chatelain E; Miles MA; Moraes CB
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():107-120. PubMed ID: 32688218
[TBL] [Abstract][Full Text] [Related]
16. Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.
Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM
Antimicrob Agents Chemother; 2015 Aug; 59(8):4653-61. PubMed ID: 26014936
[TBL] [Abstract][Full Text] [Related]
17. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
Guedes PM; Urbina JA; de Lana M; Afonso LC; Veloso VM; Tafuri WL; Machado-Coelho GL; Chiari E; Bahia MT
Antimicrob Agents Chemother; 2004 Nov; 48(11):4286-92. PubMed ID: 15504854
[TBL] [Abstract][Full Text] [Related]
18. Cure of experimental Chagas' disease by the bis-triazole DO870 incorporated into 'stealth' polyethyleneglycol-polylactide nanospheres.
Molina J; Urbina J; Gref R; Brener Z; Rodrigues Júnior JM
J Antimicrob Chemother; 2001 Jan; 47(1):101-4. PubMed ID: 11152439
[TBL] [Abstract][Full Text] [Related]
19. Benznidazole self-emulsifying delivery system: A novel alternative dosage form for Chagas disease treatment.
Mazzeti AL; Oliveira LT; Gonçalves KR; Schaun GC; Mosqueira VCF; Bahia MT
Eur J Pharm Sci; 2020 Mar; 145():105234. PubMed ID: 31978590
[TBL] [Abstract][Full Text] [Related]
20. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT
Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
